Couple Awarded $5.5M in Transvaginal Mesh Case
A couple in Bakersfield was recently awarded $5.5 million in a groundbreaking verdict against the maker of a transvaginal mesh implant after a jury determined the company sold the product even though they knew it was unsafe.
The FDA has received thousands of reports about complications with mesh devices used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) in women.
C.R. Bard Trial and Verdict
After the plaintiff was surgically implanted with the Avaulta Mesh implant (made by C.R. Bard Medical) to correct a leaky bladder, she began having complications. The device cut into her colon and tissue grew through the holes in the mesh; she had to have eight surgeries to correct the damage.
The woman sued C.R. Bard claiming the company knew the device was unsafe and sold it anyway. She was awarded $5 million and her husband was awarded an additional $500,000 for the effect it had on the couple’s love life.
Avaulta Mesh Removed from Market
- On January 3, 2012, after years of public warnings about transvaginal mesh products, the FDA finally ordered 31 transvaginal mesh manufacturers, including C.R. Bard, to conduct further testing on the devices.
- On July 1, 2012, C.R. Bard discontinued U.S. sales of their Avaulta Mesh product because the FDA wanted more clinical trials conducted.
- An estimated 47,000 women have had this particular brand of mesh implanted and there are currently 650 lawsuits pending over this product.
Transvaginal Mesh Complications
Transvaginal mesh patches are woven mesh implants that cover the vaginal wall to support damaged tissue. Complications include:
- Urinary problems
- Mesh erosion through the vagina
- Narrowing of the vaginal wall
- Recurrence of prolapse and/or incontinence
- Bowel, bladder, and blood vessel perforation during insertion
Experienced Defective Medical Device Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side effects from the use of transvaginal mesh or transvaginal mesh patches, contact Thomas J. Henry immediately. We are available 24/7, nights and weekends.